In the latest Bench to Bedside column, clinicians provide information and resources on recommended topics learners should explore.
This technology is effective in cases that are difficult to diagnose.
Salmonella becomes more dangerous as antimicrobial resistance grows. Read about its most common manifestations.
Four lessons learned from the AIDS crisis that can be applied to the fight against our current pandemic.
"This case gives uncomfortable insight into a gap in early detection of infections in immunocompromised, high-risk patient populations. "
This agent is likely best utilized as part of a combination when treating this bacterium but data regarding appropriate combinations are scarce.
A patient presented with a history of uncontrolled HIV and a history of polysubstance use.
Emergency departments (EDs) are an important entry point into the health care system and have been identified as a location with opportunity for increased HIV diagnosis and management.
Despite hepatitis C (HCV) incidence rates increasing, adequate screening for the virus continues to be a pressing challenge for public health officials.
Escalating usage and more drug choices are putting more people at risk.
This market has seen a flurry of activity, as shown by a review of the latest agents.
Although the pandemic halted many medical mission assignments, these opportunities and others are becoming available to help those geographic areas with acute needs.
For patients undergoing surgery, looking at the potential benefits of this antimicrobial for prophylaxis.
Epidemiologic and clinical lessons for the uninitiated.
Will there be an answer to keep the continuously evolving virus at bay? Are seasonal combination vaccines the wave of the future?
Extending antimicrobial stewardship programs to transition of care and discharge may prove beneficial to reduce unnecessary antibiotic use.
Tina Tan, MD; Wendy Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP; Priya Nori, MD; Jacinda Abdul-Mutakabbir, PharmD; and Kevin Michael Reiter, MD, PA, provide key takeaways from the discussion on the treatment of respiratory viral infections.
This week, NYC has revealed high rates of Hepatitis C virus reinfection, SHEA tackles antimicrobial resistance amidst challenges during the COVID-19 pandemic, and more this week from Contagion.
A review of the data and circumstances that led to authorization in children ages 5 to 11 years.
Conflicting priorities of infection control, antimicrobial stewardship, and critical care make the management of sepsis secondary to SARS-CoV-2 infection challenging.
Conflicting priorities of infection control, antimicrobial stewardship, and critical care make the management of sepsis secondary to SARS-CoV-2 infection challenging.
This bipartisan initiative highlights the need for a comprehensive approach to combat antimicrobial resistance (AMR), incorporating both antibiotic drug development and increased funding for stewardship programs.
Traditional therapy coverage does not include recent data that offers some updates in evaluating the current effectiveness of empiric antibiotic treatment.
How pharmacists can use shared decision-making to improve antibiotic use.
Experts provide practice pearls for educating patients on and using FMTs for the management of CDI.
Will there be an answer to keep the continuously evolving virus at bay? Are seasonal combination vaccines the wave of the future?
Four lessons learned from the AIDS crisis that can be applied to the fight against our current pandemic.
In the latest article from SIDP, here is a look at therapy options addressing this emerging clinical challenge.
The challenging search for a metric that effectively evaluates an ASP’s direct impact on appropriate antimicrobial use and improved patient outcomes.